ARTICLE | Product Development
COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
April 8, 2020 12:46 AM UTC
Updated on Apr 8, 2020 at 1:27 AM UTC
The same day President Donald Trump said the U.S. will cut off funding to the WHO, the Wellcome Trust announced an $8 billion fund for COVID-19 R&D, with more than a billion earmarked for the global health organization. The day also saw Ridgeback and Karyopharm plan trials for their respective COVID-19 candidates.
Speaking at a White House briefing, Trump criticized the WHO for opposing the U.S. ban on travelers from China, and accused the international organization of missing the start of the COVID-19 pandemic...